BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12532903)

  • 1. [Biofilms and their significance in medical microbiology].
    Cernohorská L; Votava M
    Epidemiol Mikrobiol Imunol; 2002 Nov; 51(4):161-4. PubMed ID: 12532903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and control of biofilm-based medical-device-related infections.
    Francolini I; Donelli G
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):227-38. PubMed ID: 20412300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilms in ear, nose, and throat infections: how important are they?
    Vlastarakos PV; Nikolopoulos TP; Maragoudakis P; Tzagaroulakis A; Ferekidis E
    Laryngoscope; 2007 Apr; 117(4):668-73. PubMed ID: 17415138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antibacterials on biofilms.
    Aslam S
    Am J Infect Control; 2008 Dec; 36(10):S175.e9-11. PubMed ID: 19084156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quorum sensing in biofilms--how to destroy the bacterial citadels or their cohesion/power?
    Lazar V
    Anaerobe; 2011 Dec; 17(6):280-5. PubMed ID: 21497662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of biofilm formation in device-associated clinical bacterial isolates in a tertiary level hospital.
    Mulla SA; Revdiwala S
    Indian J Pathol Microbiol; 2011; 54(3):561-4. PubMed ID: 21934221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival strategies of infectious biofilms.
    Fux CA; Costerton JW; Stewart PS; Stoodley P
    Trends Microbiol; 2005 Jan; 13(1):34-40. PubMed ID: 15639630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition.
    Chaignon P; Sadovskaya I; Ragunah Ch; Ramasubbu N; Kaplan JB; Jabbouri S
    Appl Microbiol Biotechnol; 2007 May; 75(1):125-32. PubMed ID: 17221196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical significance and new therapeutical strategies for biofilm associated infections.
    Lazăr V; Chifiriuc MC
    Roum Arch Microbiol Immunol; 2010; 69(3):125-38. PubMed ID: 21434589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections.
    Passerini de Rossi B; Calenda M; Vay C; Franco M
    Rev Argent Microbiol; 2007; 39(4):204-12. PubMed ID: 18390153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial diversity in biofilm infections of the urinary tract with the use of sonication techniques.
    Holá V; Ruzicka F; Horka M
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):525-8. PubMed ID: 20602639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biofilms, tolerance and antimicrobial resistance].
    Bahar G
    Mikrobiyol Bul; 2002; 36(3-4):343-51. PubMed ID: 12838670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurring and antimicrobial-resistant infections:considering the potential role of biofilms in clinical practice.
    Saye DE
    Ostomy Wound Manage; 2007 Apr; 53(4):46-8, 50, 52 passim. PubMed ID: 17449916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and removal of pathogenic biofilms on medical implant surfaces.
    Dunlop P; Oliver L; Byrne T; McAdams E
    Stud Health Technol Inform; 2005; 117():213-7. PubMed ID: 16282672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion to medical device materials and biofilm formation capability of some species of enterococci in different physiological states.
    Lleo M; Bonato B; Tafi MC; Caburlotto G; Benedetti D; Canepari P
    FEMS Microbiol Lett; 2007 Sep; 274(2):232-7. PubMed ID: 17651395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycocalyx, biofilm, microbes, and resistant infection.
    Gristina AG; Shibata Y; Giridhar G; Kreger A; Myrvik QN
    Semin Arthroplasty; 1994 Oct; 5(4):160-70. PubMed ID: 10155159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?
    Kirisits MJ; Parsek MR
    Cell Microbiol; 2006 Dec; 8(12):1841-9. PubMed ID: 17026480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm in implant infections: its production and regulation.
    Costerton JW; Montanaro L; Arciola CR
    Int J Artif Organs; 2005 Nov; 28(11):1062-8. PubMed ID: 16353112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.
    Tamilvanan S; Venkateshan N; Ludwig A
    J Control Release; 2008 May; 128(1):2-22. PubMed ID: 18342974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.